Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-14.59M
Cash
27.8M
Avg Qtr Burn
-4.817M
Short % of Float
0.31%
Insider Ownership
1.22%
Institutional Own.
6.17%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Macimorelin (Macrilen®; GHRYVELIN™) Details Pediatric growth hormone deficiency | Phase 3 Data readout |